# Everbright

> Everbright is a VC fund in Wan Chai backing Health Care and Manufacturing. See 54 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Wan Chai, Hong Kong
- Total investments: 54
- Last investment: Jul 2026
- Lead investor: 20%
- Fund size: $539M
- Last fund: Jan 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/china-everbright-limited/
- Website: https://www.everbright.com
- Facebook: https://www.facebook.com/ChinaEverbrightLimited/

Everbright is a VC fund in Wan Chai focused on Health Care and Manufacturing. Everbright is China’s cross-border investment and asset management company.

## Contacts

5 contacts available for Everbright. Shizune tracks 8 team members at Everbright. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/everbright?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 17% |
| Manufacturing | 9 | 17% |
| Biotechnology | 8 | 15% |
| Medical | 6 | 11% |
| Software | 5 | 9% |

81 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 18 | 33% |
| Series C | 8 | 15% |
| Series B | 7 | 13% |
| Series D | 5 | 9% |
| Funding Round | 5 | 9% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 37 | 69% |
| United States | 4 | 7% |
| Iceland | 1 | 2% |
| Hong Kong | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chen Shuang | Executive Director and CEO | 0 | https://shizune.co/investors/profile/chen-shuang |
| Jiang Yuanzhi | Executive Director and Chief Investment Officer | 0 | https://shizune.co/investors/profile/jiang-yuanzhi |
| Tang Chi Chung Richard | Executive Director and CFO | 0 | https://shizune.co/investors/profile/tang-chi-chung-richard |
| Tsang Frederick Sui Cheong | Chief Risk Officer | 0 | https://shizune.co/investors/profile/tsang-frederick-sui-cheong |
| Wong Tung Hung | Chief Administration Officer | 0 | https://shizune.co/investors/profile/wong-tung-hung |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ractigen Therapeutics | Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery made at the University of California San Francisco (UCSF) known as RNA activation(RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need. | $31M | Venture - Series Unknown | Jul 29, 2026 |  |
| Topband Huachuang | Topband is a membrane material technology developer, mainly engaged in the research and development of special separation membrane materials. Its products are widely used in new energy, semiconductor, coal chemical and other fields. | $14.7M | Series C | May 26, 2026 |  |
| YoungEn Technology | YoungEn Technology is an automation equipment company that specializes in providing automated, intelligent production equipment solutions. |  | Series B | Jan 07, 2026 |  |
| KYinno | KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer. | $35.5M | Series B | Dec 15, 2025 |  |
| Xinyi Electronic Technology | Xinyi Electronics is an artificial intelligence application software developer, focusing on 5G communication technology services, artificial intelligence application software development, integrated circuits, semiconductor device special equipment, integrated circuit chips and products. |  | Series A | Jul 17, 2025 |  |
| Terminus Technologies | Terminus Group is an international leading Al smart service provider, shaping the next generation of technology with Artificial Intelligence & Internet of Things (AloT). They are mission driven, and are devoted to providing our customers with high quality products, which focused on AI cities, sustainable development, and robotics. They aim touse their AloT engine to integrate standalone products into smart solutions, eventually paving the way to a world of interconnected AI cities. | $276.6M | Series D | Apr 09, 2024 |  |
| Reforgene Medicine | Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases. | $15M | Series B | Apr 28, 2023 |  |
| Grit Science | Grit Science is a gene therapeutics firm, that engages in the R&D of liver genes. | $15M | Series A | Mar 02, 2022 |  |
| Innogen Pharmaceutical | Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. | $120M | Series A | Dec 23, 2021 |  |
| Yinuo Pharmaceutical | Yinuo Pharmaceuticals is a small molecule inhibitor drug developer. | $120M | Series A | Dec 23, 2021 |  |

10 of 54 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 7 deals together
- [China Growth Capital](https://shizune.co/investors/profile/china-growth-capital) — VC Fund, 6 deals together
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 3 deals together
- [Frees Fund](https://shizune.co/investors/profile/freesfund) — VC Fund, 3 deals together
- [Source Code Capital](https://shizune.co/investors/profile/source-code-capital) — VC Fund, 3 deals together
- [CD Capital](https://shizune.co/investors/profile/cd-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Retail Investors in China](https://shizune.co/investors/retail-investors-china)
- [Retail Investors in Asia](https://shizune.co/investors/retail-investors-asia)

## FAQ

### What does Everbright invest in?

Everbright invests primarily in Health Care, Manufacturing and Biotechnology startups, most often at Series A and Series C stage. Most of the 54 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Everbright?

Public channels for Everbright include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Everbright?

The team at Everbright includes Chen Shuang (Executive Director and CEO), Jiang Yuanzhi (Executive Director and Chief Investment Officer) and Tang Chi Chung Richard (Executive Director and CFO), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co